-
-
-
-
-
-
-
Maxim Group Downgrades Longeveron (LGVN) to Hold
-
-
-
-
-
-
-
Longeveron presents MRI data on stem cell therapy for Alzheimer's
-
-
-
-
-
-
-
Longeveron (LGVN) Appoints Than Powell as Chief Business Officer
-
-
-
-
-
-
-
Longeveron (LGVN) Reports FY24 Results, Provides Business Update
-
-
-
-
-
-
-
Longeveron (LGVN) Announces Positive Type C Meeting with FDA Regarding Pathway to BLA for Lomecel-B
-
-
-
-
-
-
-
Longeveron (LGVN) Exercises $4.4M Worth of Warrants
-
458,818 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

